Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Oligodendroglioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Testing effectiveness (Phase 2)UnknownNCT00276783
What this trial is testing

Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer
Northwestern University 31
Early research (Phase 1)UnknownNCT00083096
What this trial is testing

Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 30
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Ended earlyNCT01721577
What this trial is testing

Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more
Rush University Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT00275067
What this trial is testing

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 50
Early research (Phase 1)Study completedNCT00611728
What this trial is testing

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Who this might be right for
Glioblastoma
Duke University 25
Not applicableApproved For MarketingNCT05592743
What this trial is testing

Vorasidenib Expanded Access Program

Who this might be right for
GliomaRecurrenceDisease Attributes+10 more
Servier
Early research (Phase 1)Study completedNCT00063973
What this trial is testing

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Looking for participantsNCT04923126
What this trial is testing

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

Who this might be right for
Low-Grade GliomaRecurrent Low-Grade GliomaProgressive Low-Grade Glioma
St. Jude Children's Research Hospital 132
Early research (Phase 1)Looking for participantsNCT06254326
What this trial is testing

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

Who this might be right for
Recurrent OligodendrogliomaProgressive Oligodendroglioma
University of Florida 12
Testing effectiveness (Phase 2)Study completedNCT00012038
What this trial is testing

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Early research (Phase 1)Active Not RecruitingNCT05561374
What this trial is testing

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma

Who this might be right for
High-grade GliomaOligodendrogliomaAstrocytoma+1 more
Oblato, Inc. 16
Early research (Phase 1)UnknownNCT00516607
What this trial is testing

Enzastaurin and Temozolomide in Treating Patients With Primary Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 28
Testing effectiveness (Phase 2)Study completedNCT03969706
What this trial is testing

Abemaciclib in Patients With Oligodendroglioma

Who this might be right for
Oligodendroglioma, Adult
Stephen Bagley, MD, MSCE 10
Large-scale testing (Phase 3)Active Not RecruitingNCT00978458
What this trial is testing

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System TumorsNeurotoxicity
Eastern Cooperative Oncology Group 540
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Next Page